Relmada Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:RLMD) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -27.81 M-91.87 M-103.8 M-51.66 M-51.76 M-45.79 M -42.79 M Cash from investing activities -34.45 M-54.12 M19.73 M50.45 M51.56 M-48.14 M -198.73 M Cash from financing activities 28.47 M187.94 M45.02 M-98.46 K-40.34 K93.56 M 250.14 M Free cash flow -209.86 M-91.87 M-103.8 M-51.66 M-51.76 M-45.79 M -42.79 M

News

Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call Transcript

Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript

Mizuho reiterates Relmada stock rating on positive cancer trial data

RLMD Stock Surges 42% in a Week: Here's What You Should Know

Avago, Lumentum among market cap stock movers on Monday

Tesla and Facebook among market cap stock movers on Monday

Mizuho reiterates Relmada stock rating on bladder cancer trial data

Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip

Relmada Therapeutics stock surges 25% on bladder cancer data

Relmada reports 76% response rate for bladder cancer therapy